+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glycopeptides"

Glycopeptide Antibiotics Global Market Report 2024 - Product Thumbnail Image

Glycopeptide Antibiotics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Antibiotic Resistance Global Market Report 2024 - Product Thumbnail Image

Antibiotic Resistance Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Antibiotics Global Market Report 2024 - Product Thumbnail Image

Antibiotics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Vancomycin Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Vancomycin Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
Antibiotic Drug Resistance. Edition No. 1 - Product Thumbnail Image

Antibiotic Drug Resistance. Edition No. 1

  • Book
  • October 2019
  • 720 Pages
Antibiotics and Antibiotic Resistance. Edition No. 1 - Product Thumbnail Image

Antibiotics and Antibiotic Resistance. Edition No. 1

  • Book
  • November 2011
  • 224 Pages
  • 11 Results (Page 1 of 1)
Loading Indicator

Glycopeptides are a class of antibiotics used to treat serious bacterial infections. They are derived from a polysaccharide-peptide backbone and are effective against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Glycopeptides are typically used in combination with other antibiotics to treat infections that are resistant to other antibiotics. They are also used to prevent infections in patients who are immunocompromised or undergoing surgery. Glycopeptides are generally more expensive than other antibiotics, and their use is limited due to their narrow spectrum of activity. However, they are an important part of the antibiotic arsenal and are used in cases where other antibiotics are ineffective. Some companies in the glycopeptides market include Merck, Pfizer, AstraZeneca, and GlaxoSmithKline. Show Less Read more